Mobidiag, Genewave and Amplidiag Announce Definitive Agreement

News   Apr 15, 2013

 
Mobidiag, Genewave and Amplidiag Announce Definitive Agreement
 
 
 

RELATED ARTICLES

New Rapid Test for Valley Fever Should Help Reduce Diagnosis Delays

News

November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.

READ MORE

Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories Forward

News

First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.

READ MORE

Cracking the Code of Coenzyme Q Biosynthesis

News

Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE